We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Studying Presentation of Risk Information in DTC Advertising
FDA Studying Presentation of Risk Information in DTC Advertising
March 16, 2007
The FDA will conduct two studies to investigate how the context and format of risk information in direct-to-consumer (DTC) print advertisements influence consumers’ understanding of drug risks.